The George Institute for Global Health, Kent St, Sydney, Australia.
BMC Health Serv Res. 2012 Aug 21;12:267. doi: 10.1186/1472-6963-12-267.
In order to assist health service planning, understanding factors that influence higher trauma treatment costs is essential. The majority of trauma costing research reports the cost of trauma from the perspective of the receiving hospital. There has been no comprehensive synthesis and little assessment of the drivers of cost variation, such as country, trauma, subgroups and methods. The aim of this review is to provide a synthesis of research reporting the trauma treatment costs and factors associated with higher treatment costs in high income countries.
A systematic search for articles relating to the cost of acute trauma care was performed and included studies reporting injury severity scores (ISS), per patient cost/charge estimates; and costing methods. Cost and charge values were indexed to 2011 cost equivalents and converted to US dollars using purchasing power parities.
A total of twenty-seven studies were reviewed. Eighty-one percent of these studies were conducted in high income countries including USA, Australia, Europe and UK. Studies either reported a cost (74.1%) or charge estimate (25.9%) for the acute treatment of trauma. Across studies, the median per patient cost of acute trauma treatment was $22,448 (IQR: $11,819-$33,701). However, there was variability in costing methods used with 18% of studies providing comprehensive cost methods. Sixty-three percent of studies reported cost or charge items incorporated in their cost analysis and 52% reported items excluded in their analysis. In all publications reviewed, predictors of cost included Injury Severity Score (ISS), surgical intervention, hospital and intensive care, length of stay, polytrauma and age.
The acute treatment cost of trauma is higher than other disease groups. Research has been largely conducted in high income countries and variability exists in reporting costing methods as well as the actual costs. Patient populations studied and the cost methods employed are the primary drivers for the treatment costs. Targeted research into the costs of trauma care is required to facilitate informed health service planning.
为了协助卫生服务规划,了解影响高创伤治疗费用的因素至关重要。大多数创伤成本研究从接收医院的角度报告创伤成本。还没有综合的综合分析,也很少评估成本变化的驱动因素,如国家、创伤、亚组和方法。本综述的目的是综合报告高收入国家急性创伤治疗费用和与较高治疗费用相关的因素。
系统检索与急性创伤护理成本相关的文章,并纳入报告创伤严重程度评分(ISS)、每位患者成本/费用估算以及成本计算方法的研究。成本和费用值以 2011 年成本等价物为索引,并使用购买力平价转换为美元。
共审查了 27 项研究。其中 81%的研究在高收入国家进行,包括美国、澳大利亚、欧洲和英国。这些研究要么报告了创伤急性治疗的成本(74.1%),要么报告了费用估计值(25.9%)。在所有研究中,急性创伤治疗的每位患者平均费用为 22448 美元(IQR:11819-33701 美元)。然而,使用的成本计算方法存在差异,18%的研究提供了全面的成本计算方法。63%的研究报告了纳入成本分析的成本或费用项目,52%的研究报告了排除在分析之外的项目。在所有审查的出版物中,成本的预测因素包括损伤严重程度评分(ISS)、手术干预、医院和重症监护、住院时间、多发伤和年龄。
创伤的急性治疗费用高于其他疾病组。研究主要在高收入国家进行,报告成本计算方法以及实际成本存在差异。研究的患者人群和使用的成本方法是治疗费用的主要驱动因素。需要对创伤护理成本进行有针对性的研究,以促进卫生服务规划。